The Phase 2 study of oral, once-daily mavorixafor was a six-month, open-label clinical trial that enrolled a total of 23 ...

Candel Therapeutics announced an oral presentation ... in the Company’s filings with the U.S. Securities and Exchange Commission (SEC) including the Company’s most recent Annual Report on ...

The City of Tulsa and the Tulsa Area United Way (TAUW) released the seventh annual Tulsa Equality Indicators report on ...

today announced the Company will exhibit four poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting, which is being held from May 13-17, 2025, in New ...

Abbey Mortgage Bank Plc, a renowned financial institution in Nigeria, will hold its 33rd Annual General Meeting (AGM) on ...

STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) held its 2025 Annual Meeting ... gave a business presentation, which included an overview of ...

Q1 2025 Earnings Call May 8, 2025 8:30 AM ETCompany ParticipantsSean Fitzgerald - Investor RelationsBalan Nair ...

Sonida Senior Living, Inc. ( NYSE: SNDA) Q1 2025 Results Conference Call May 12, 2025 11:00 AM ET Jason Finkelstein - Investor Relations Brandon Ribar - President and CEO Kevin Detz - Chief Financial ...

Operator: Good afternoon, everyone, and welcome to the GEN Restaurant Group, Incorporated First Quarter 2025 Earnings Call.

--(BUSINESS WIRE)--Arcus Biosciences ... Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30 – June 3, 2025. The oral presentation will highlight the first safety and efficacy ...

The Jacksonville History Center presented its annual Jacksonville’s Endangered Historic Properties report May 14 in the ...

About Arcadia Biosciences, Inc. Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in ...